Positive Results From Phase II Trial Of Rituxan In RRMS
Main Category: Multiple Sclerosis News
Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) ... more »
|
|||||
|
Multiple Sclerosis Info
Search
This Month
|
Monday, September 25
Positive Results From Phase II Trial Of Rituxan In RRMS
by
multiplesclerosis
on Mon 25 Sep 2006 12:00 AM CST
|
||||